Strategic Wealth Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Strategic Wealth Investment Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.59M	Sell	17,849 -752	-4%	-$55.8K	0.24%	55
2023 Q3	$1.36M	Sell	18,601 -344	-2%	-$27.5K	0.25%	53
2023 Q2	$1.58M	Sell	18,945 -5,784	-23%	-$484K	0.25%	63
2023 Q1	$1.88M	Buy	24,729 +3,978	+19%	+$330K	0.35%	56
2022 Q4	$1.78M	Buy	20,751 +95	+0.5%	+$7.69K	0.41%	52
2022 Q3	$1.64M	Buy	20,656 +3,998	+24%	+$337K	0.47%	48
2022 Q2	$1.24M	Buy	16,658 +2,262	+16%	+$170K	0.31%	68
2022 Q1	$1.29M	Buy	14,396 +4,016	+39%	+$371K	0.31%	48
2021 Q4	$1.16M	Buy	10,380 +804	+8%	+$97K	0.3%	50
2021 Q3	$1.22M	Buy	9,576 +1,889	+25%	+$243K	0.37%	47
2021 Q2	$1.04M	Buy	7,687 +2,284	+42%	+$300K	0.37%	44
2021 Q1	$733K	Buy	5,403 +440	+9%	+$65.9K	0.35%	47
2020 Q4	$699K	Buy	4,963 +383	+8%	+$49.1K	0.41%	49
2020 Q3	$510K	Buy	4,580 +484	+12%	+$54.3K	0.38%	55
2020 Q2	$459K	Buy	+4,096	New	+$403K	0.45%	53

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CHP

Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Strategic Wealth Investment Group's XBI Position: Q4 2023 in Review

Strategic Wealth Investment Group reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4% in Q4 2023, selling an estimated $55.8K and leaving 17,849 shares worth $1.59M. The position accounts for 0.24% of the portfolio, ranked #55.

Strategic Wealth Investment Group first reported a position in XBI in Q2 2020 and has held it in 15 quarters since. The position peaked at $1.88M in Q1 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

Strategic Wealth Investment Group held 17,849 shares of State Street SPDR S&P Biotech ETF worth $1.59M as of Q4 2023.
Strategic Wealth Investment Group sold 752 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $55.8K.
State Street SPDR S&P Biotech ETF made up 0.24% of Strategic Wealth Investment Group's portfolio in Q4 2023, its #55 holding.
Strategic Wealth Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 15 quarters since.
Strategic Wealth Investment Group's State Street SPDR S&P Biotech ETF position peaked at $1.88M in Q1 2023.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Strategic Wealth Investment Group's 13F filing for Q4 2023, filed 16 Jan 2024.